Three different things a first reply can mean
Patients often read a short reply as a green light. In practice, replies fall into three groups, and they call for different responses. The first is a receipt acknowledgement: the hospital or international office has logged your file and may give a reference number. Nothing clinical has been assessed. The second is a records request: someone has looked at the file, found it incomplete for the question you asked, and wants specific documents before a specialist can comment. The third is a review-stage reply: a named department or clinician has been asked to give an opinion, and the reply tells you that this is in progress or gives a preliminary view.
The wording matters less than the question you send back. Ask directly: is this a receipt confirmation, a request for more records, or a clinical review? If it is a review, ask whether the review concerns a new regimen or your ongoing treatment. Those are different questions, and they need different records. A hospital assessing a possible new line of chemotherapy needs the story of what has already been given and how the cancer responded. A hospital assessing continuation or adjustment of current treatment needs the current plan, the cycle you are in, and the monitoring results so far.
Do not treat a polite reply as a treatment promise. Hospital acceptance, regimen choice and start dates are clinical and administrative decisions made by the treating team after they have the information they need. A preliminary reply is the beginning of that process, not the end of it.
Why the reply may ask for more records
Chemotherapy uses drugs to kill or slow the growth of cancer cells, and treatment schedules differ according to the prescribed regimen. Because schedules differ, a clinician reviewing your case cannot judge much from a diagnosis alone. They need to see the treatment history in order: which drugs, in which combinations, at what intervals, and what happened after each stage. That is why a records request is a normal and useful reply, not a rejection.
A frequent gap is a summary without the underlying reports. A short letter saying 'received chemotherapy' does not tell a reviewer whether the disease responded, stabilised or progressed, and it does not show whether treatment was stopped for toxicity, patient choice or another reason. Pathology and staging reports, imaging reports with dates, operation notes if surgery happened, and the current medication and cycle record all help. If you have a discharge summary from the most recent admission, that can be a particularly useful document to include.
When you send more records, label them clearly and keep a list of what you sent and when. If a document is unavailable, say so rather than leaving the reviewer to assume it does not exist. Ask which specific items are still missing for the question being reviewed, so you are not sending an entire archive again.
New regimen or ongoing treatment: ask which review you are in
This is the single most useful clarifying question after a preliminary reply. If you are asking about a new regimen, the reviewer needs to understand prior lines of therapy, the reason each was stopped, and the current disease status. If you are asking about continuing or adjusting treatment you are already receiving, the reviewer needs your current regimen, the cycle number, the date of the last dose, and recent blood counts and imaging. Sending the wrong set slows the reply and can produce a vague answer.
It also changes what you should ask about timing. For ongoing treatment, the practical question is how a transition between treating teams would be coordinated so that cycles are not interrupted. For a new regimen, the question is whether the hospital can offer the assessment and, if so, what further tests or consultations it would need first. Neither question can be answered from a diagnosis alone, and neither should be assumed from a friendly first email.
Write your question in one sentence at the top of your next message: 'Please confirm whether this review is for a new regimen or for continuation of my current treatment.' Then list the documents you have attached. This makes it easy for the international office to route your file correctly.
What a preliminary reply does not confirm
A first reply does not confirm that the hospital will accept you as a patient, that a particular regimen is available, that a bed or appointment slot is reserved, or that treatment can begin on a date you have in mind. It also does not confirm cost. If you need an estimate, ask the hospital what its written quote would include and exclude, and which items are still undecided because the plan is not final. Do not rely on a general figure from a website or a verbal indication in an email.
It is also worth separating the roles. A hospital decides clinical suitability and writes the treatment plan. A coordination service can help with records, translation, appointment requests and practical arrangements, but it does not prescribe, dispense medicines or decide whether you are suitable for a regimen. If someone tells you that a reply means you are 'approved' for chemotherapy, ask them to show you where the treating clinician has said so in writing.
Finally, a preliminary reply is not a reason to delay care you need now. If your condition is worsening or you have urgent symptoms, contact your current treating team or local emergency services first. An overseas enquiry can continue in parallel.
How cycles and monitoring would be coordinated
If the review moves forward, the next practical discussion is coordination. Chemotherapy is given in cycles, and monitoring between cycles is part of the plan, not an optional extra. Ask how the hospital would structure this for an international patient: where blood tests and assessments would take place, how results would be shared with the treating team, and what would happen if a cycle needed to be delayed for any reason. These are questions for the clinical team, and the answers depend on your regimen and your condition.
Ask also who your main point of contact would be once a plan is agreed, and how changes to the plan are communicated. For a patient travelling from abroad, unclear responsibility between an international office, a ward and an outpatient clinic is a common source of confusion. A written summary of the agreed plan, including the regimen name, cycle length and monitoring arrangements, is more useful than a series of separate messages.
If you are already mid-treatment, ask how the handover would work in practice: which records the new team needs, who contacts your current clinician if clarification is needed, and how the gap between cycles would be managed. The receiving team makes its own assessment; it is reasonable to ask how they prefer to receive information from your current team.
Your next message and a brief next step
Keep your reply short and specific. Confirm which stage you understand the review to be in, ask whether it concerns a new regimen or ongoing treatment, list the records you have already sent, and ask which specific documents are still needed. If you want an estimate, ask for a written quote and what it includes. If you want an appointment, ask what has actually been confirmed and what remains provisional.
If you would like help organising records, interpreting a reply or requesting a specialist appointment, ChinaSpecialistCare can assist with that coordination. An initial enquiry is free and does not require buying a proxy consultation; the hospital decides suitability. You can start with a brief summary of your diagnosis, previous regimens and current question, and send fuller records after first contact.
For background on how chemotherapy planning is approached for international patients in China, see the chemotherapy planning reference.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.